- Zacks•18 hours ago
Boston Scientific Corporation (BSX) is scheduled to report fourth-quarter and full-year 2016 results before the opening bell on Feb 2.
- TheStreet.com•9 days ago
The technical signs indicate the stage may be set for new highs in the maker of medical devices.
- The Wall Street Journal•11 days ago
Medtronic is facing new competition in supplying devices for deep brain stimulation, an established therapy for moderating the symptoms of Parkinson’s disease.
BSX : Summary for Boston Scientific Corporation C - Yahoo Finance
Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||23.71 - 23.99|
|52 Week Range||15.67 - 24.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||450.57|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|